ℹ️
🇬🇧
Search
Search for publications relevant for "GLP‑1 receptor agonist"
GLP‑1 receptor agonist
Publication
Class
Person
Publication
Programmes
Export current view
publication
Benefits of GLP-1 receptor agonists therapy for patients with cardiovascular disease
2022 |
First Faculty of Medicine
publication
The effect of GLP‑1 receptor agonists on improving glucose control and decreasing body weight: results of direct comparative trials and network meta‑analysis
2022 |
First Faculty of Medicine
publication
An update on the safety of insulin-GLP-1 receptor agonist combinations in type 2 diabetes mellitus
2022 |
First Faculty of Medicine
publication
Cardiovascular effects of GLP-1 receptor agonist treatment: focus on liraglutide
2015 |
First Faculty of Medicine
publication
Lixisenatide - a novel prandial GLP-1 receptor agonist
2013 |
Second Faculty of Medicine
publication
The Effect of GLP-1 Receptor Agonists on Postprandial Lipaemia
2022 |
First Faculty of Medicine
publication
Komentář k článku Inhibitory SGLT2 a GLP-1 receptoroví agonisté u diabetu 2. typu: rychlé doporučení BMJ
2022 |
First Faculty of Medicine
publication
Incretin-Based Treatment Strategy - GLP-1 Receptor Agonists (GLP-1R) or So-Called Incretin Mimetics
2011 |
First Faculty of Medicine
publication
Incretin-Based- Treatment Strategy - GLP-1 Receptor Agonists (GLP-1R) or So-Called Incretin Mimetics
2011 |
Second Faculty of Medicine
publication
Modern treatment of diabetes in questions and responses
2014 |
First Faculty of Medicine
publication
Practical view of insulin therapy intensification with fixed combination injection therapy of liraglutide and degludec
2017 |
First Faculty of Medicine
publication
Pharmacological modulation of body weight in patients with diabetes
2017 |
First Faculty of Medicine
publication
New antidiabetic drugs - availability of more effective treatment
2017 |
First Faculty of Medicine
publication
Dulaglutide
2018 |
First Faculty of Medicine
publication
Incretin-based treatment of diabetes and cardiovascular complications
2020 |
First Faculty of Medicine
publication
Effect of the use of lixisenatide in antidiabetic therapy intensification
2015 |
First Faculty of Medicine
publication
Nephroprotective effects of selected antidiabetics
2021 |
Third Faculty of Medicine
publication
How will diabetes treatment change with new pharmaceuticals?
2015 |
Second Faculty of Medicine
publication
Incretin therapy and diabetic retinopathy
2013 |
Second Faculty of Medicine
publication
Incretins have changed and continue to change treatment strategy for type 2 diabetes
2011 |
Second Faculty of Medicine
publication
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes
2023 |
First Faculty of Medicine
publication
Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide
2018 |
Publication without faculty affiliation
publication
Obesity treatment in patients both with and without diabetes: current options and perspectives
2020 |
First Faculty of Medicine
publication
Dulaglutide and Incident Atrial Fibrillation or Flutter in patients with type 2 Diabetes; a post-hoc analysis from the REWIND Randomized Trial
2022 |
Publication without faculty affiliation
publication
Oral semaglutide in the treatment of type 2 diabetes
2020 |
First Faculty of Medicine
publication
Victoza - a strong ally
2015 |
Faculty of Medicine in Hradec Králové
publication
Five years of experience with liraglutide
2015 |
Second Faculty of Medicine
publication
Lixisenatide
2013 |
Second Faculty of Medicine
publication
Semaglutide in the treatment of type 2 diabetes mellitus
2019 |
First Faculty of Medicine
publication
Individualization of therapy for type 2 diabetes: GLP-1 agonists
2015 |
First Faculty of Medicine